ReviewCancer management and research2016

Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectives.

Nellowe Candelario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.